ZAMBON, Alfonso
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.468
EU - Europa 5.504
AS - Asia 5.236
SA - Sud America 780
AF - Africa 140
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 5
Totale 22.143
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.257
SG - Singapore 1.683
IT - Italia 1.463
CN - Cina 1.225
GB - Regno Unito 1.096
HK - Hong Kong 967
DE - Germania 785
SE - Svezia 643
BR - Brasile 590
VN - Vietnam 566
PL - Polonia 277
FR - Francia 240
RU - Federazione Russa 222
FI - Finlandia 198
UA - Ucraina 164
KR - Corea 161
IN - India 124
CA - Canada 108
ID - Indonesia 93
BG - Bulgaria 77
NL - Olanda 72
TR - Turchia 71
MX - Messico 69
BD - Bangladesh 64
AR - Argentina 57
IE - Irlanda 47
JP - Giappone 43
ES - Italia 41
EC - Ecuador 39
BE - Belgio 37
IQ - Iraq 34
ZA - Sudafrica 33
CO - Colombia 32
MA - Marocco 31
AT - Austria 29
MY - Malesia 28
AE - Emirati Arabi Uniti 23
VE - Venezuela 22
PK - Pakistan 21
IR - Iran 18
CH - Svizzera 16
DZ - Algeria 15
EG - Egitto 15
TH - Thailandia 15
LT - Lituania 14
RO - Romania 13
UZ - Uzbekistan 13
CL - Cile 12
KE - Kenya 12
PH - Filippine 12
TN - Tunisia 12
CZ - Repubblica Ceca 11
PY - Paraguay 11
SA - Arabia Saudita 10
AU - Australia 8
IL - Israele 8
PE - Perù 8
PT - Portogallo 8
BY - Bielorussia 7
DO - Repubblica Dominicana 7
GE - Georgia 7
JO - Giordania 7
HU - Ungheria 6
RS - Serbia 6
AZ - Azerbaigian 5
DK - Danimarca 5
ET - Etiopia 5
KZ - Kazakistan 5
LK - Sri Lanka 5
NP - Nepal 5
TT - Trinidad e Tobago 5
AL - Albania 4
BO - Bolivia 4
LB - Libano 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
AO - Angola 3
CR - Costa Rica 3
HN - Honduras 3
JM - Giamaica 3
KG - Kirghizistan 3
LU - Lussemburgo 3
OM - Oman 3
PA - Panama 3
UY - Uruguay 3
XK - ???statistics.table.value.countryCode.XK??? 3
BH - Bahrain 2
BS - Bahamas 2
BZ - Belize 2
EE - Estonia 2
EU - Europa 2
GR - Grecia 2
HR - Croazia 2
LV - Lettonia 2
MK - Macedonia 2
ML - Mali 2
NG - Nigeria 2
NI - Nicaragua 2
SI - Slovenia 2
UG - Uganda 2
Totale 22.116
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.106
Singapore 1.104
Fairfield 1.030
Hong Kong 942
Ashburn 898
Woodbridge 629
Southend 576
Chandler 568
Houston 495
Modena 481
Ann Arbor 439
Nyköping 384
Seattle 381
Cambridge 375
Hefei 372
Frankfurt am Main 350
San Jose 330
Wilmington 327
London 293
Warsaw 256
Beijing 249
Jacksonville 227
Dearborn 222
Ho Chi Minh City 190
Helsinki 176
Los Angeles 165
Council Bluffs 150
The Dalles 148
Dallas 147
Hanoi 145
Chicago 142
Seoul 140
Berlin 106
Bologna 95
New York 88
San Diego 85
Princeton 75
Reggio Emilia 74
Sofia 74
Bremen 73
Eugene 65
Lauterbourg 65
Jakarta 63
Moscow 60
Salt Lake City 58
Boardman 54
Orem 52
São Paulo 49
Munich 45
Dublin 42
Buffalo 40
Shanghai 39
Milan 37
Parma 34
Redondo Beach 34
Formigine 33
Brussels 32
Amsterdam 31
Izmir 31
Tokyo 31
Da Nang 30
Redwood City 30
Tampa 27
Atlanta 26
Montreal 25
Chennai 24
Stockholm 24
Denver 22
Toronto 22
Wimbledon 22
Bomporto 21
Kent 21
Rio de Janeiro 21
Vancouver 21
Elk Grove Village 20
Falls Church 19
Norwalk 19
Rome 19
Brooklyn 18
Newark 17
Nuremberg 17
Voghera 17
Belo Horizonte 16
Johannesburg 16
Lappeenranta 16
Mexico City 16
Haiphong 15
Madrid 15
Paris 15
Phoenix 15
Des Moines 14
Florence 14
Guangzhou 14
Manchester 14
Turin 14
Guayaquil 13
Poplar 13
Tashkent 13
Columbus 12
Dhaka 12
Totale 15.741
Salva come PNG Salva come JPEG
Nome #
1 - ( 5 - TERT - BUTYL - 2 - ARYL - PYRAZOL - 3 - YL ) . 3 - 12 - FLUORO - 4 - [ ( 3 - OXO - 4H - PYRIDO [ 2 . 3 - BJPYRAZIN - 8 - YL ) OXY | PHENYLJUREA DERIVATIVES AS RAF INHIBITORS FOR THE TREATMENT OF CANCER 967
Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure-Activity Relationships 574
Chiral polycyclic ketones via desymmetrization of dihaloolefins 429
Potential of wickerhamomyces anomalus in glycerol valorization 412
Cytocompatibility of potential bioactive cerium-doped glasses based on 45S5 373
BRAF inhibitors induce metastasis in RAS mutant or inhibitor-resistant melanoma cells by reactivating MEK and ERK signaling 357
Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanoma 349
Nucleoside 2’,3’-cyclic monophosphates in Aphanizomenon flos-aquae detected through nuclear magnetic resonance and mass spectrometry 344
A novel mechanism for the fluxional behaviour of [Pd(η2-tetramethylethylenetetracarboxylate)(2-methylthiomethylpyridine)] 335
A novel protocol for the one-pot borylation/Suzuki reaction provides easy access to hinge-binding groups for kinase inhibitors 327
Cerium Containing Bioactive Glasses: A Review 323
Abstract 3704: Novel panRAF inhibitors active in melanomas that are resistant to BRAF-selective, or BRAF-selective/MEK inhibitor combinations 322
A novel, selective, and efficacious nanomolar pyridopyrazinone inhibitor of V600EBRAF 316
BRAF inhibitors based on an imidazo[4,5]pyridin-2-one scaffold and a meta substituted middle ring 313
Assessment of chloroaniline toxicity by the submitochondrial particle assay 310
Development of novel, highly potent inhibitors of V-RAF murine sarcoma viral oncogene homologue B1 (BRAF): Increasing cellular potency through optimization of a distal heteroaromatic group 303
Characterization of compound 584, an Abl kinase inhibitor with lasting effects 302
BRAF as a therapeutic target: A patent review (2006-2012) 301
Mesoporous bioactive glasses doped with cerium: Investigation over enzymatic-like mimetic activities and bioactivity 300
Boosting sunscreen stability: New hybrid materials from UV filters encapsulation 300
Novel hinge binder improves activity and pharmacokinetic properties of BRAF inhibitors 293
Structure Model and Toxicity of the Product of Biodissolution of Chrysotile Asbestos in the Lungs 292
Investigation on the antimicrobial properties of cerium-doped bioactive glasses 283
1-(5-tert-butyl-2-phenyl-2H-pyrazol-3-yl)-3-[2-fluoro-4-(1-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-B]pyridin-7-yloxy)-phenyl]-urea and related compounds and their use in therapy 273
Thiophene based A-D-A small molecules with a dithienosilole core: synthesis, theoretical calculations and optoelectronic properties 270
β-Glucuronidase Pattern Predicted From Gut Metagenomes Indicates Potentially Diversified Pharmacomicrobiomics 265
Ce-MBGs Loaded with Gentamicin: Characterization and In Vitro Evaluation 260
Development and exploitation of CK2 inhibitors 256
Tris-annelated benzenes selectively perfunctionalized on one side only: Hexachlorobenzotrinorbornadiene as a versatile scaffold for the construction of molecular domes 255
Novel Potent BRAF Inhibitors: Toward 1 nM Compounds through Optimization of the Central Phenyl Ring 250
The discovery of novel, highly potent inhibitors of BRAF 248
Non canonical Cyclic Nucleotides Monophosphates in Aphanizomenon flosaquae: nuclear magnetic resonance and mass spectrometry 244
Synthesis, structure-activity relationship and crystallographic studies of 3-substituted indolin-2-one RET inhibitors 242
"Hexacarboxytrindanes": Benzene rings with homotopic faces as scaffolds for the construction of D3 chiral architectures 241
Potent BRAF kinase inhibitors based on 2,4,5-trisubstituted imidazole with naphthyl and benzothiophene 4-substituents 240
Substituted aniline interaction with submitochondrial particles and quantitative structure-activity relationships 239
Novel tricyclic pyrazole BRAF inhibitors with imidazole or furan central scaffolds 235
Study on the toxicity of phenolic and phenoxy herbicides using the submitochondrial particle assay 234
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors 233
Efficient access to 5-substituted thiazoles by a novel metallotropic rearrangement 232
1-(5-TERT-BUTYL-2-ARYL-PYRAZOL-3-YL)-3-2-FLUORO-4-(3-OXO-4H-PYRIDO2,3-BPYRAZIN-8-YL)OXYPHENYLUREA DERIVATIVES AS RAF INHIBITORS FOR THE TREATMENT OF CANCER 229
Internal motions in a fulleropyrrolidine tertiary amide with axial chirality 228
Surface acidity modifications induced by thermal treatments and acid leaching on microcrystalline H-BEA zeolite. A FTIR, XRD and MAS-NMR study 228
Pyridoimidazolones as novel potent inhibitors of v-Raf murine sarcoma viral oncogene homologue B1 (BRAF) 228
Topical 5-Fluorouracil Elicits Regressions of BRAF Inhibitor–Induced Cutaneous Squamous Cell Carcinoma 228
Synthesis of the syn and anti isomer of 1,4,5,8,9,12-hexahydro-2,3,6,7,10,11-hexamethylidene-1,4 : 5,8 : 9,12-trimethanotriphenylene and Diels-Alder reactivity of the syn isomer 228
Isolation and characterization of all eight bisadducts of fulleropyrrolidine derivatives 227
Novel oligothiophenes with reduced HOMO-LUMO band gap for Optoelectonics 224
Gatekeeper mutations mediate resistance to BRAF-targeted therapies 222
Synthesis and evaluation of antiparasitic activities of new 4-[5-(4-phenoxyphenyl)-2H-pyrazol-3-yl]morpholine derivatives 221
Synthesis and evaluation of new chiral diols based on the dicyclopentadiene skeleton 217
Small molecule inhibitors of BRAF in clinical trials 216
ANTIPROLIFERATIVE COMPOUNDS AND THERAPEUTIC USES THEREOF 215
Loading with Biomolecules Modulates the Antioxidant Activity of Cerium-Doped Bioactive Glasses 215
Nucleophilic reactions at the ring carbons of thiiranium and thiirenium ions. An experimental and theoretical comparison of the S(N)2 and S(N)2-Vin mechanisms 210
Bifunctional mesoporous glasses for bone tissue engineering: Biological effects of doping with cerium and polyphenols in 2D and 3D in vitro models 209
Efficient cyclotrimerization of bicyclic vic-bromostannylalkenes promoted by copper(I) thiophen-2-carboxylate 207
Dual Kinase Targeting in Leukemia 205
Qualitative and quantitative discrimination of fake and true alkene rotation processes in pd(η2-olefin) complexes. A new bimolecular mechanism 199
ANTIPROLIFERATIVE COMPOUNDS AND THERAPEUTIC USES THEREOF 198
Expedient Access to Type II Kinase Inhibitor Chemotypes by Microwave-Assisted Suzuki Coupling 198
Inhibiting EGF receptor or SRC family kinase signaling overcomes BRAF inhibitor resistance in melanoma 197
Non-canonical Cyclic Nucleoside Monophosphates in Aphanizomenon flos-aquae: nuclear magnetic resonance and mass spectrometry 190
Evaluation of the Properties of Bioactive Mesoporous Glasses Doped with Cerium and Loaded with Polyphenols 188
Biostimulants derived from organic urban wastes and biomasses: An innovative approach 177
Synthetic approach to novel NMP/ALK inhibitors 173
Cytocompatibility of mesoporous bioactive glasses doped with cerium and loaded with polyphenols 170
Toward the Scale-Up of a Bicyclic Homopiperazine via Schmidt Rearrangement and Photochemical Oxaziridine Rearrangement in Continuous-Flow 168
Paradoxical activation of the MEK/ERK pathway promotes melanoma invasion and metastasis 164
α‐Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML 163
Rational design of inhibitors of the anaplastic lymphoma kinase 161
NON CANONICAL CYCLIC NUCLEOTIDES MONOPHOSPHATES IN APHANIZOMENON FLOS-AQUAE: NUCLEAR MAGNETIC RESONANCE AND MASS SPECTROMETRY 159
endo-1-Phenylborneol as a novel, alternative chiral auxiliary for the aza-Diels-Alder reaction 158
LYSYL OXIDASE INHIBITORS 155
Evaluation of the behaviour of hydrogels containing mesoporous glasses doped with cerium and loaded with polyphenols 154
Erratum: Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase (ACS Omega (2022) 7:20 (17083-17097) DOI: 10.1021/acsomega.2c00507) 154
Extraction, purification and in vitro assessment of the antioxidant and anti-inflammatory activity of policosanols from non-psychoactive Cannabis sativa L. 153
Identification of non-ATP-competitive α-carboline inhibitors of the anaplastic lymphoma kinase 150
Dual loaded Ce-MBGs with bioactivity, antioxidant and antibacterial properties 149
Discovery of Novel α-Carboline Inhibitors of the Anaplastic Lymphoma Kinase 143
Preparation of 1-​(5-​tert-​butyl-​2-​aryl-​pyrazol-​3-​yl)​-​3-​[2-​fluoro-​4-​[(3-​oxo-​4H-​pyrido[2,​3-​b]​pyrazin-​8-​yl)​oxy]​phenyl]​urea derivatives as RAF inhibitors for treating cancer 136
The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers 134
Double-ion doped mesoporous glasses: Studies on stability, antibacterial and antioxidant properties, and bioactivity 129
New pan-ALK inhibitor-resistant EML4::ALK mutations detected by liquid biopsy in lung cancer patients 127
Erratum: Paradox-Breaking RAF Inhibitors that Also Target SRC Are Effective in Drug-Resistant BRAF Mutant Melanoma (Cancer Cell (2015) 27(1) (85–96) (S1535610814004577) (10.1016/j.ccell.2014.11.006)) 122
Novel ligands from direct benzylic functionalisation of tris(2-pyridylmethyl)amine 119
Long-term durability of discarded cork-based composites obtained by geopolymerization 113
Corrections to pyridoimidazolones as novel potent inhibitors of v-raf murine sarcoma viral oncogene homologue B1 (BRAF) (Journal of Medicinal Chemistry (2009) 52, (2255-2256) DOI: 10.1021/jm801509w) 106
PROCESS FOR THE PREPARATION OF 8-(4-AMINOPHENOXY)-4H PYRIDO2,3-B PYRAZIN-3-ONE DERIVATIVES 105
Polyphosphate coacervate gels for manufacturing of manganese loaded glass powders and fibres: structural, cytocompatibility and surface bioactivity study 103
Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1 99
Erratum: Topical 5-fluorouracil elicits regressions of BRAF inhibitor-induced cutaneous squamous cell carcinoma (Journal of Investigative Dermatology (2013) 133 (274-276) DOI: 10.1038/jid.2012.268;0 97
Enhanced bone regeneration with cerium-doped bioactive glasses: In vitro and in vivo study 94
Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype 72
Materiale fotoassorbente ad ampio spettro, procedimento per la sua preparazione ed usi relativi 71
Gelatin/Cerium-Doped Bioactive Glass Composites for Enhancing Cellular Functions of Human Mesenchymal Stem Cells (hBMSCs) 70
Negative Allosteric Modulators of A2AR: A New Weapon for Cancer Immunotherapy? 67
Targeting monocarboxylate transporter 1 with a copper-chelating coumarin-based bioconjugate: Synthesis and characterization 65
Discovery of selective, metabolically stable pyrazole-based FLT3 inhibitors for the treatment of acute myeloid leukemia 61
UV filters Encapsulation in Zeolites 49
Totale 22.259
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.178
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021254 0 0 0 0 0 0 0 0 0 0 135 119
2021/20221.666 95 210 201 58 73 89 99 82 188 96 288 187
2022/20231.967 245 218 134 187 258 249 71 176 246 46 76 61
2023/20241.625 52 94 110 97 514 43 278 178 43 48 52 116
2024/20254.053 126 43 125 203 806 566 214 319 564 224 398 465
2025/20267.369 425 326 694 901 1.077 999 887 422 736 765 137 0
Totale 22.306